Funding for this research was provided by:
Fujian Province Science and Technology Innovation Joint Fund Project (2021Y9029)
Malignant Tumor Clinical Medicine Research Center, Quanzhou City, Fujian Province, China (2020N090s)
Article History
Received: 18 October 2023
Accepted: 29 December 2023
First Online: 21 January 2024
Declarations
:
: The authors declare that they have no competing interests.
: This study was approved by the Ethics Committee of the hospital. Informed consent individual patients were waived because of the retrospective nature of the analysis.
: Not applicable.